Ionis Pharmaceuticals, Inc. Increase (Decrease) in Other Employee-Related Liabilities
Ionis Pharmaceuticals, Inc. (IONS) reported Increase (Decrease) in Other Employee-Related Liabilities of -$65.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherEmployeeRelatedLiabilities · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for the quarter ending 2026-06-30 was $14.24M, a 28.74% decline year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for the quarter ending 2026-03-31 was -$80.19M.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for the quarter ending 2025-12-31 was $59.22M, a 103.80% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for the quarter ending 2025-09-30 was $10.46M, a 88.72% increase year-over-year.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for fiscal 2025 was $46.62M, a 2370.69% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for fiscal 2024 was $1.89M, a 89.83% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for fiscal 2023 was $18.55M, a 78.91% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. increase (decrease) in other employee-related liabilities for fiscal 2022 was $10.37M.
| Period end | Increase (Decrease) in Other Employee-Related Liabilities 3 month | Increase (Decrease) in Other Employee-Related Liabilities 6 month | Increase (Decrease) in Other Employee-Related Liabilities 9 month | Increase (Decrease) in Other Employee-Related Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$65.94M 10-Q · filed 2026-07-29 | -$6.73M derived: sum of 3 quarters · filed 2026-07-29 | $3.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$80.19M 10-Q · filed 2026-04-29 | -$20.97M derived: sum of 2 quarters · filed 2026-04-29 | -$10.52M derived: sum of 3 quarters · filed 2026-04-29 | $9.47M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $59.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $69.67M derived: sum of 2 quarters · filed 2026-02-26 | $89.66M derived: sum of 3 quarters · filed 2026-07-29 | $46.62M 10-K · filed 2026-02-26 |
| 2025-09-30 | $10.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $30.44M derived: sum of 2 quarters · filed 2026-07-29 | -$12.60M 10-Q · filed 2025-10-29 | $16.46M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $19.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$23.05M 10-Q · filed 2026-07-29 | $6.01M derived: sum of 3 quarters · filed 2026-07-29 | $11.55M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$43.04M 10-Q · filed 2026-04-29 | -$13.98M derived: sum of 2 quarters · filed 2026-04-29 | -$8.44M derived: sum of 3 quarters · filed 2026-04-29 | $5.04M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $29.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $34.60M derived: sum of 2 quarters · filed 2026-02-26 | $48.08M derived: sum of 3 quarters · filed 2026-02-26 | $1.89M 10-K · filed 2026-02-26 |
| 2024-09-30 | $5.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $19.02M derived: sum of 2 quarters · filed 2025-10-29 | -$27.17M 10-Q · filed 2025-10-29 | $6.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $13.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$32.71M 10-Q · filed 2025-07-30 | $1.24M derived: sum of 3 quarters · filed 2026-02-26 | $5.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$46.19M 10-Q · filed 2025-04-30 | -$12.24M derived: sum of 2 quarters · filed 2026-02-26 | -$7.79M derived: sum of 3 quarters · filed 2026-02-26 | $3.38M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $33.95M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $38.41M derived: sum of 2 quarters · filed 2026-02-26 | $49.57M derived: sum of 3 quarters · filed 2026-02-26 | $18.55M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $15.62M derived: sum of 2 quarters · filed 2024-11-06 | -$15.40M 10-Q · filed 2024-11-06 | $3.37M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $11.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$19.86M 10-Q · filed 2024-08-01 | -$1.09M derived: sum of 3 quarters · filed 2025-02-19 | $4.34M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | -$31.02M 10-Q · filed 2024-05-07 | -$12.25M derived: sum of 2 quarters · filed 2025-02-19 | -$6.83M derived: sum of 3 quarters · filed 2025-02-19 | $1.64M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $18.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $24.19M derived: sum of 2 quarters · filed 2025-02-19 | $32.65M derived: sum of 3 quarters · filed 2025-02-19 | $10.37M 10-K · filed 2025-02-19 |
| 2022-09-30 | $5.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $13.88M derived: sum of 2 quarters · filed 2023-11-02 | -$8.40M 10-Q · filed 2023-11-02 | -$1.91M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $8.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$13.82M 10-Q · filed 2023-08-09 | -$7.33M derived: sum of 3 quarters · filed 2024-02-21 | -$5.24M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | -$22.29M 10-Q · filed 2023-05-03 | -$15.79M derived: sum of 2 quarters · filed 2024-02-21 | -$13.70M derived: sum of 3 quarters · filed 2024-02-21 | -$12.74M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $6.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $8.59M derived: sum of 2 quarters · filed 2024-02-21 | $9.55M derived: sum of 3 quarters · filed 2024-02-21 | -$26.92M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.06M derived: sum of 2 quarters · filed 2022-11-09 | -$33.41M 10-Q · filed 2022-11-09 | $3.93M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $959.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$35.51M 10-Q · filed 2022-08-09 | $1.83M derived: sum of 3 quarters · filed 2023-02-22 | $7.40M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$36.47M 10-Q · filed 2022-05-04 | $873.00K derived: sum of 2 quarters · filed 2023-02-22 | $6.44M derived: sum of 3 quarters · filed 2023-02-22 | $12.83M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $37.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $42.91M derived: sum of 2 quarters · filed 2023-02-22 | $49.29M derived: sum of 3 quarters · filed 2023-02-22 | $28.37M 10-K · filed 2023-02-22 |
| 2020-09-30 | $5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $11.95M derived: sum of 2 quarters · filed 2021-11-03 | -$8.97M 10-Q · filed 2021-11-03 | $3.99M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $6.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$14.54M 10-Q · filed 2021-08-04 | -$1.58M derived: sum of 3 quarters · filed 2022-02-25 | $2.77M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$20.92M 10-Q · filed 2021-05-05 | -$7.97M derived: sum of 2 quarters · filed 2022-02-25 | -$3.61M derived: sum of 3 quarters · filed 2022-02-25 | $173.00K derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $12.95M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $17.31M derived: sum of 2 quarters · filed 2022-02-25 | $21.09M derived: sum of 3 quarters · filed 2022-02-25 | $8.09M 10-K · filed 2022-02-25 |
| 2019-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $8.14M derived: sum of 2 quarters · filed 2020-11-04 | -$4.86M 10-Q · filed 2020-11-04 | $145.00K derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $3.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$9.22M 10-Q · filed 2020-08-05 | -$4.21M derived: sum of 3 quarters · filed 2021-02-24 | $4.96M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$13.00M 10-Q · filed 2020-05-06 | -$8.00M derived: sum of 2 quarters · filed 2021-02-24 | $1.18M derived: sum of 3 quarters · filed 2021-02-24 | $4.10M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $14.18M derived: sum of 2 quarters · filed 2021-02-24 | $17.10M derived: sum of 3 quarters · filed 2021-02-24 | $4.12M 10-K · filed 2021-02-24 |
| 2018-09-30 | $9.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $12.09M derived: sum of 2 quarters · filed 2019-11-06 | -$892.00K 10-Q · filed 2019-11-06 | $9.07M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $2.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$10.06M 10-Q · filed 2019-08-08 | -$98.00K derived: sum of 3 quarters · filed 2020-03-02 | $4.79M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$12.98M 10-Q · filed 2019-05-09 | -$3.02M derived: sum of 2 quarters · filed 2020-03-02 | $1.87M derived: sum of 3 quarters · filed 2020-03-02 | $3.90M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $14.85M derived: sum of 2 quarters · filed 2020-03-02 | $16.88M derived: sum of 3 quarters · filed 2020-03-02 | $965.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $4.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $6.92M derived: sum of 2 quarters · filed 2018-11-06 | -$9.00M 10-Q · filed 2018-11-06 | $4.18M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$13.89M 10-Q · filed 2018-08-07 | -$710.00K derived: sum of 3 quarters · filed 2019-03-01 | $2.86M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | -$15.92M 10-Q · filed 2018-05-07 | -$2.74M derived: sum of 2 quarters · filed 2019-03-01 | $826.00K derived: sum of 3 quarters · filed 2019-03-01 | $1.93M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $16.75M derived: sum of 2 quarters · filed 2019-03-01 | $17.85M derived: sum of 3 quarters · filed 2019-03-01 | $8.12M 10-K · filed 2019-03-01 |
| 2016-09-30 | $3.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.67M derived: sum of 2 quarters · filed 2017-11-07 | -$5.06M 10-Q · filed 2017-11-07 | $1.50M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$8.62M 10-Q · filed 2017-08-09 | -$2.07M derived: sum of 3 quarters · filed 2018-02-28 | -$474.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$9.73M 10-Q · filed 2017-05-09 | -$3.17M derived: sum of 2 quarters · filed 2018-02-28 | -$1.58M derived: sum of 3 quarters · filed 2018-02-28 | $926.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $6.56M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $8.15M derived: sum of 2 quarters · filed 2018-02-28 | $10.65M derived: sum of 3 quarters · filed 2018-02-28 | $3.76M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.10M derived: sum of 2 quarters · filed 2016-11-09 | -$2.79M 10-Q · filed 2016-11-09 | $2.34M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$4.39M 10-Q · filed 2016-08-09 | $751.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.49M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$6.89M 10-Q · filed 2016-05-05 | -$1.75M derived: sum of 2 quarters · filed 2017-03-01 | -$1.02M derived: sum of 3 quarters · filed 2017-03-01 | $1.08M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $5.87M derived: sum of 2 quarters · filed 2017-03-01 | $7.97M derived: sum of 3 quarters · filed 2017-03-01 | $134.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $734.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $2.84M derived: sum of 2 quarters · filed 2015-11-09 | -$5.00M 10-Q · filed 2015-11-09 | $511.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$5.74M 10-Q · filed 2015-08-05 | -$223.00K derived: sum of 3 quarters · filed 2016-02-26 | -$601.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$7.84M 10-Q · filed 2015-05-05 | -$2.33M derived: sum of 2 quarters · filed 2016-02-26 | -$2.70M derived: sum of 3 quarters · filed 2016-02-26 | $510.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $5.14M derived: sum of 2 quarters · filed 2016-02-26 | $8.35M derived: sum of 3 quarters · filed 2016-02-26 | $4.29M 10-K · filed 2016-02-26 |
| 2013-09-30 | -$378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $2.83M derived: sum of 2 quarters · filed 2014-11-07 | -$1.23M 10-Q · filed 2014-11-07 | |
| 2013-06-30 | $3.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$847.00K 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | -$4.06M 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | -$1.30M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $2.35M 10-K · filed 2014-03-03 | |||
| 2010-12-31 | $394.00K 10-K · filed 2013-02-28 | |||
| 2009-12-31 | -$4.37M 10-K · filed 2012-02-29 | |||
| 2008-12-31 | -$3.25M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |